Inhibiting fatty acid amide hydrolase normalizes endotoxin-induced enhanced gastrointestinal motility in mice

Bacterial cell products signal to mouse colonic nociceptive dorsal root ganglia neurons

(2010) Fernando Ochoa-Cortes et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Evidence for both inverse agonism at the cannabinoid CB1 receptor and the lack of an endogenous cannabinoid tone in the rat and guinea-pig isolated ileum myenteric plexus-longitudinal muscle preparation

(2010) R Makwana et al.   BRITISH JOURNAL OF PHARMACOLOGY

Effects of cannabinoids and cannabinoid-enrichedCannabisextracts on TRP channels and endocannabinoid metabolic enzymes

(2010) Luciano De Petrocellis et al.   BRITISH JOURNAL OF PHARMACOLOGY

Inhibitor of Fatty Acid Amide Hydrolase Normalizes Cardiovascular Function in Hypertension without Adverse Metabolic Effects

(2010) Grzegorz Godlewski et al.   CHEMISTRY & BIOLOGY

Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions

(2010) Lena Öhman et al.   Nature Reviews Gastroenterology & Hepatology

Cannabinoids and the gut: New developments and emerging concepts

(2010) Angelo A. Izzo et al.   PHARMACOLOGY & THERAPEUTICS

Targeting Fatty Acid Amide Hydrolase (FAAH) to Treat Pain and Inflammation

(2009) Joel E. Schlosburg et al.   AAPS Journal

Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis

(2009) Martin A. Storr et al.   INFLAMMATORY BOWEL DISEASES

The identification of peroxisome proliferator-activated receptor alpha-independent effects of oleoylethanolamide on intestinal transit in mice

(2009) n. l. cluny et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Involvement of cannabinoid-1 and cannabinoid-2 receptors in septic ileus

(2009) y.-y. li et al.   NEUROGASTROENTEROLOGY AND MOTILITY

The endocannabinoid system: Its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation

(2009) Vincenzo Di Marzo   PHARMACOLOGICAL RESEARCH

Ulcerative Colitis Induces Changes on the Expression of the Endocannabinoid System in the Human Colonic Tissue

(2009) Lucia Marquéz et al.   PLoS One

The role of fatty acid hydrolase gene variants in inflammatory bowel disease

(2008) M. STORR et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats

(2008) Marnie Duncan et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Cannabidiol, extracted fromCannabis sativa, selectively inhibits inflammatory hypermotility in mice

(2008) R Capasso et al.   BRITISH JOURNAL OF PHARMACOLOGY

Enzymatic Pathways That Regulate Endocannabinoid Signaling in the Nervous System

(2008) Kay Ahn et al.   CHEMICAL REVIEWS

Cannabinoid Receptor Activation Induces Apoptosis through Tumor Necrosis Factor  -Mediated Ceramide De novo Synthesis in Colon Cancer Cells

(2008) F. Cianchi et al.   CLINICAL CANCER RESEARCH

Comprehensive profiling of the human circulating endocannabinoid metabolome: clinical sampling and sample storage parameters

(2008) JodiAnne T. Wood et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects

(2008) A A Izzo et al.   GUT

Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors

(2008) Martin A. Storr et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB1receptors and fatty acid amide hydrolase

(2008) d. de filippis et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Genetic variation in endocannabinoid metabolism, gastrointestinal motility, and sensation

(2007) Michael Camilleri et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Cannabinoid CB2receptors in the gastrointestinal tract: a regulatory system in states of inflammation

(2007) K L Wright et al.   BRITISH JOURNAL OF PHARMACOLOGY

Evaluation of fatty acid amides in the carrageenan-induced paw edema model

(2007) Laura E. Wise et al.   NEUROPHARMACOLOGY

The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition

(2007) Maria Scherma et al.   NEUROPHARMACOLOGY

Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors

(2007) Fabricio A. Moreira et al.   NEUROPHARMACOLOGY

Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms

(2006) Leon Chang et al.   BRITISH JOURNAL OF PHARMACOLOGY